1.32 USD
-0.07 (-5.04%)
1.3401 USD
+0.02 (+1.52%)
XELB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. Both the profitability and financial health of XELB have multiple concerns. XELB is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year XELB has reported negative net income.
In the past year XELB has reported a negative cash flow from operations.
In the past 5 years XELB always reported negative net income.
XELB had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -53.80%, XELB is doing worse than 93.50% of the companies in the same industry.
Looking at the Return On Equity, with a value of -116.41%, XELB is doing worse than 74.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.8% | ||
| ROE | -116.41% | ||
| ROIC | N/A |
ROA(3y)-25.19%
ROA(5y)-19.15%
ROE(3y)-40.45%
ROE(5y)-30.57%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
XELB's Gross Margin of 156.91% is amongst the best of the industry. XELB outperforms 100.00% of its industry peers.
XELB's Gross Margin has improved in the last couple of years.
XELB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 156.91% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.58%
GM growth 5Y4.65%
2. Health
2.1 Basic Checks
XELB does not have a ROIC to compare to the WACC, probably because it is not profitable.
XELB has less shares outstanding than it did 1 year ago.
The number of shares outstanding for XELB has been reduced compared to 5 years ago.
The debt/assets ratio for XELB is higher compared to a year ago.
2.2 Solvency
XELB has an Altman-Z score of -3.60. This is a bad value and indicates that XELB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.60, XELB is doing worse than 87.80% of the companies in the same industry.
A Debt/Equity ratio of 0.48 indicates that XELB is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.48, XELB perfoms like the industry average, outperforming 53.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.6 |
ROIC/WACCN/A
WACC10.42%
2.3 Liquidity
XELB has a Current Ratio of 0.51. This is a bad value and indicates that XELB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.51, XELB is not doing good in the industry: 92.68% of the companies in the same industry are doing better.
A Quick Ratio of 0.51 indicates that XELB may have some problems paying its short term obligations.
XELB has a Quick ratio of 0.51. This is comparable to the rest of the industry: XELB outperforms 48.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 50.50% over the past year.
The Revenue for XELB has decreased by -46.66% in the past year. This is quite bad
XELB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -27.67% yearly.
EPS 1Y (TTM)50.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.33%
Revenue 1Y (TTM)-46.66%
Revenue growth 3Y-39.84%
Revenue growth 5Y-27.67%
Sales Q2Q%-41.53%
3.2 Future
Based on estimates for the next years, XELB will show a small growth in Earnings Per Share. The EPS will grow by 3.79% on average per year.
Based on estimates for the next years, XELB will show a decrease in Revenue. The Revenue will decrease by -9.31% on average per year.
EPS Next Y-41.64%
EPS Next 2Y4.25%
EPS Next 3Y3.79%
EPS Next 5YN/A
Revenue Next Year-40.58%
Revenue Next 2Y4.54%
Revenue Next 3Y-9.31%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for XELB. In the last year negative earnings were reported.
Also next year XELB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.25%
EPS Next 3Y3.79%
5. Dividend
5.1 Amount
No dividends for XELB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
1.32
-0.07 (-5.04%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners17.77%
Inst Owner Change3.2%
Ins Owners28.76%
Ins Owner Change12.45%
Market Cap6.35M
Revenue(TTM)4.98M
Net Income(TTM)-21.77M
Analysts82.5
Price Target5.1 (286.36%)
Short Float %3.49%
Short Ratio0.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.25%
Min EPS beat(2)27.45%
Max EPS beat(2)53.05%
EPS beat(4)3
Avg EPS beat(4)26.48%
Min EPS beat(4)-3.39%
Max EPS beat(4)53.05%
EPS beat(8)7
Avg EPS beat(8)38.16%
EPS beat(12)9
Avg EPS beat(12)26.68%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-20.64%
Min Revenue beat(2)-29.58%
Max Revenue beat(2)-11.69%
Revenue beat(4)0
Avg Revenue beat(4)-30.53%
Min Revenue beat(4)-43.05%
Max Revenue beat(4)-11.69%
Revenue beat(8)1
Avg Revenue beat(8)-17.21%
Revenue beat(12)3
Avg Revenue beat(12)-9.18%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-37.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4800%
EPS NY rev (1m)0%
EPS NY rev (3m)-186.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-47.77%
Revenue NY rev (1m)-3.91%
Revenue NY rev (3m)-57.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.27 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.98
EYN/A
EPS(NY)-2.09
Fwd EYN/A
FCF(TTM)-1.38
FCFYN/A
OCF(TTM)-1.37
OCFYN/A
SpS1.04
BVpS3.89
TBVpS-2.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.8% | ||
| ROE | -116.41% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 156.91% | ||
| FCFM | N/A |
ROA(3y)-25.19%
ROA(5y)-19.15%
ROE(3y)-40.45%
ROE(5y)-30.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.58%
GM growth 5Y4.65%
F-Score2
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 0.28% | ||
| Cap/Sales | 0.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 | ||
| Altman-Z | -3.6 |
F-Score2
WACC10.42%
ROIC/WACCN/A
Cap/Depr(3y)2.47%
Cap/Depr(5y)7.52%
Cap/Sales(3y)0.99%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.33%
EPS Next Y-41.64%
EPS Next 2Y4.25%
EPS Next 3Y3.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-46.66%
Revenue growth 3Y-39.84%
Revenue growth 5Y-27.67%
Sales Q2Q%-41.53%
Revenue Next Year-40.58%
Revenue Next 2Y4.54%
Revenue Next 3Y-9.31%
Revenue Next 5YN/A
EBIT growth 1Y37.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.6%
EBIT Next 3Y27.18%
EBIT Next 5YN/A
FCF growth 1Y-8.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.82%
OCF growth 3YN/A
OCF growth 5YN/A
XCEL BRANDS INC / XELB FAQ
What is the fundamental rating for XELB stock?
ChartMill assigns a fundamental rating of 1 / 10 to XELB.
What is the valuation status of XCEL BRANDS INC (XELB) stock?
ChartMill assigns a valuation rating of 0 / 10 to XCEL BRANDS INC (XELB). This can be considered as Overvalued.
What is the profitability of XELB stock?
XCEL BRANDS INC (XELB) has a profitability rating of 1 / 10.
Can you provide the financial health for XELB stock?
The financial health rating of XCEL BRANDS INC (XELB) is 2 / 10.
What is the expected EPS growth for XCEL BRANDS INC (XELB) stock?
The Earnings per Share (EPS) of XCEL BRANDS INC (XELB) is expected to decline by -41.64% in the next year.